These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12439216)

  • 1. Interview-based conclusions about rural versus urban HIV care: questions about the questions.
    Hoadley D; Mera R; Bosfield E; Schwarzberg F; Levin J; Farrell B
    J Acquir Immune Defic Syndr; 2002 Nov; 31(3):365-7; author reply 367-8. PubMed ID: 12439216
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylaxis against Pneumocystis carinii pneumonia at higher CD4+ T-cell counts.
    Chu SY; Hanson DL; Ciesielski C; Ward JW
    JAMA; 1995 Mar; 273(11):848. PubMed ID: 7869553
    [No Abstract]   [Full Text] [Related]  

  • 3. Withdrawal of prophylaxis against Pneumocystis carinii pneumonia.
    Feinberg J
    Lancet; 1999 Apr; 353(9161):1287. PubMed ID: 10218521
    [No Abstract]   [Full Text] [Related]  

  • 4. Discontinuing Pneumocystis carinii prophylaxis.
    Girard PM
    N Engl J Med; 2001 Jan; 344(3):222-3. PubMed ID: 11172146
    [No Abstract]   [Full Text] [Related]  

  • 5. Discontinuation of primary Pneumocystis carinii prophylaxis after reconstitution of CD4 cell counts in HIV-infected children.
    Urschel S; Schuster T; Dunsch D; Wintergerst U; Hofstetter R; Belohradsky BH
    AIDS; 2001 Aug; 15(12):1589-91. PubMed ID: 11504999
    [No Abstract]   [Full Text] [Related]  

  • 6. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Bender MA; Sax PE
    N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364
    [No Abstract]   [Full Text] [Related]  

  • 7. Occurrence of Pneumocystis carinii pneumonia in HIV-1-infected patients responding to HAART: is prophylaxis discontinuation a safe tool?
    Mezzaroma I; Giovannetti A; Pinter E; Ensoli F; Aiuti F
    AIDS; 1999 Dec; 13(17):2488-9. PubMed ID: 10597798
    [No Abstract]   [Full Text] [Related]  

  • 8. Pneumocystis pneumonia in a person with a low CD4 count after stopping antiretroviral therapy.
    Ball SC
    AIDS Read; 2007 Dec; 17(12):583-6, 593. PubMed ID: 18178976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumocystis carinii pneumonia in HIV-infected patients.
    May TA; Gruta CI; Goldschmidt RH
    Am Fam Physician; 2000 Oct; 62(8):1783, 1786. PubMed ID: 11057837
    [No Abstract]   [Full Text] [Related]  

  • 10. Maintenance of chemoprophylaxis against Pneumocystis carinii despite combination antiretroviral treatment associated CD4+ T-lymphocytosis.
    Macher AM; Goosby EP
    Am J Respir Crit Care Med; 1997 Apr; 155(4):1491. PubMed ID: 9105103
    [No Abstract]   [Full Text] [Related]  

  • 11. Does Pneumocystis carinii prophylaxis still need to be lifelong?
    Masur H; Kaplan J
    N Engl J Med; 1999 Apr; 340(17):1356-8. PubMed ID: 10219072
    [No Abstract]   [Full Text] [Related]  

  • 12. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Le Moal G; Breux JP; Roblot F
    N Engl J Med; 2001 May; 344(21):1639-41. PubMed ID: 11374363
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune reconstitution in several forms.
    Ball SC
    AIDS Read; 2005 Jan; 15(1):17-20. PubMed ID: 15685730
    [No Abstract]   [Full Text] [Related]  

  • 14. Discontinuation of secondary prophylaxis for Pneumocystis pneumonia in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.
    Esposito S; Bojanin J; Porta A; Cesati L; Gualtieri L; Principi N
    Pediatr Infect Dis J; 2005 Dec; 24(12):1117-20. PubMed ID: 16371882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis carinii pneumonia in children with perinatally acquired HIV infection.
    Meyers A
    JAMA; 1994 Jan; 271(2):103. PubMed ID: 8264060
    [No Abstract]   [Full Text] [Related]  

  • 16. Pneumocystis carinii pneumonia after the discontinuation of secondary prophylaxis.
    Degen O; ven Lunzen J; Horstkotte MA; Sobottka I; Stellbrink HJ
    AIDS; 2002 Jul; 16(10):1433-4. PubMed ID: 12131226
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
    Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
    N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
    ; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
    Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early intervention therapy in HIV-infected patients: a questionnaire-based survey among French physicians.
    Landman R; Olivaries R; Girard PM; Gaudebout C; Saimot AG; Coulaud JP
    AIDS; 1994 Feb; 8(2):274-6. PubMed ID: 7913818
    [No Abstract]   [Full Text] [Related]  

  • 20. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
    Ledergerber B; Mocroft A; Reiss P; Furrer H; Kirk O; Bickel M; Uberti-Foppa C; Pradier C; D'Arminio Monforte A; Schneider MM; Lundgren JD;
    N Engl J Med; 2001 Jan; 344(3):168-74. PubMed ID: 11188837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.